Page 321 - medicina-integrativa_compress

CAPÍTULO 29 VASCULOPATÍA PERIFÉRICA 317

16. Willigendael EM, Teijink JA, Bartelink ML, et al: Influence of 41. Bauer U: Ginkgo biloba extract in the treatment of arteriopathy of
smoking on incidence and prevalence of peripheral artery disease. the lower extremities: A 65-week trial. Presse Med 15:1546, 1986.
J Vasc Surg 40:1158-1165, 2004. 42. Blume J, Kieser M, Holscher U, et al: Placebo-controlled double-
17. Jonason T, Bergstrom R: Cessation of smoking in patients with blind study of the effectiveness of Ginkgo biloba special extract EGb
intermittent claudication: Effects on the risk of peripheral vascular 761 in trained patients with intermittent claudication. Vasa 25:265,
complications, myocardial infarction, and mortality. Acta Med 1996.
Scand 221:253-260, 1987. 43. Thomson GJ, Vohra RK, Carr MH, Walker MG: A clinical trial
18. Mukherjee D, Yadav JS: Update on peripheral vascular disease: of Ginkgo biloba extract in patients with intermittent claudication.
From smoking cessation to stenting. Cleve Clin J Med 68:723-733, Int Angiol 9:75, 1990.
2001. 44. Saudreau F, Serise JM, Pillet J, et al: Efficacy of an extract of Ginkgo
19. Schillinger M, Exner M, Mlekusch W, et al: Effect of smoking on biloba in the treatment of chronic obliterative arteriopathies of the
restenosis during the first year after lower-limb endovascular lower limbs in stage III of Fontaine’s classification. J Mal Vasc
interventions. Radiology 231:831-838, 2004. 14:177, 1989.
20. Tierney S, Fennessy F, Hayes DB: ABC of arterial and vascular 45. Rudofsky G: Effect of Ginkgo biloba extract in arterial occlusive
disease: Secondary prevention of peripheral vascular disease. disease: Randomized placebo-controlled crossover study.
BMJ 320:1262-1265, 2000. Fortschr Med 105:397, 1987.
21. Aguilera CM, Mesa MD, Ramirez-Tortosa MC, et al: Sunflower oil 46. Schneider B: Ginkgo biloba extract in peripheral arterial diseases:
does not protect against LDL oxidation as virgin olive oil does in Meta-analysis of controlled clinical studies. Arzneimittelforschung
patients with peripheral vascular disease. Clin Nutr 23:673-681, 42:428, 1992.
2004. 47. Pittler MH, Ernst E: Ginkgo biloba extract for the treatment of
22. Sommerfield T, Hiatt WR: Omega-3 fatty acids for intermittent intermittent claudication: A meta-analysis of randomized trials.
claudication. Cochrane Database Syst Rev (3)CD003833, 2004. Am J Med 108:276-281, 2000.
23. Carrero JJ, Lopez-Huertas E, Salmeron LM, et al: Daily 48. Horsch S, Walther C: Ginkgo biloba special extract EGb 761 in the
supplementation with omega-3 PUFAs, oleic acid, folic acid, and treatment of peripheral arterial occlusive disease (PAOD): A review
vitamins B 6 and E increases pain-free walking distance and improves based on randomized, controlled studies. Int J Clin Pharmacol Ther
risk factors in men with peripheral vascular disease. J Nutr 42:63, 2004.
135:1393-1399, 2005. 49. Jacobs BP, Browner WS: Ginkgo biloba extract for the treatment
24. Burdge GC, Jones AE, Wootton SA: Eicosapentaenoic and of intermittent claudication: A meta-analysis of randomized trials.
docosapentaenoic acids are the principal products of alpha-linolenic Am J Med 108:279-281, 2000.
acid metabolism in young men. Br J Nutr 88:355-364, 2002. 50. Bent S, Goldberg H, Padula A, Avins AL: Spontaneous bleeding
25. Merchant A, Hu F, Spiegelman D, et al: Dietary fiber reduces associated with Ginkgo biloba: A case report and systematic review
peripheral arterial risk in men. J Nutr 133:3658-3663, 2003. of the literature. J Gen Intern Med 20:657, 2005.
26. Hung HC, Merchant A, Willett W, et al: The association between 51. Ang-Lee MK, Moss J, Yuan CS: Herbal medicines and perioperative
fruit and vegetable consumption and peripheral arterial disease. care. JAMA 286:208, 2001.
Epidemiology 14:659-665, 2003. 52. Castano G, Mas R, Arruzazabala ML, et al: Effects of policosanol and
27. Aikens JE: Thermal biofeedback for claudication in diabetes: pravastatin on lipid profile, platelet aggregation and endothelemia in
A literature review and case study. Altern Med Rev 4:104-110, 1999. older hypercholesterolemic patients. Int J Clin Pharmacol Res
28. Saunders JT, Cox DJ, Teates CD, et al: Thermal biofeedback in 19:105-116, 1999.
the treatment of intermittent claudication in diabetes: A case 53. Arruzazabala ML, Valdes S, Mas R, et al: Effect of policosanol
study. Biofeedback Self Regul 19:337-345, 1994. successive dose increases on platelet aggregation in healthy
29. Arseven A, Guralnik JM, O’Brien E, et al: Peripheral arterial volunteers. Pharmacol Res 34:181-185, 1996.
disease and depressed mood in older men and women. Vasc Med 54. Castano G, Mas Ferreiro R, Fernandez L, et al: A long-term study of
6:229-234, 2001. policosanol in the treatment of intermittent claudication. Angiology
30. McDermott MM, Greenland P, Guralnik JM, et al: Depressive 52:115-125, 2001.
symptoms and lower extremity functioning in men and women with 55. Castano G, Mas R, Roca J, et al: A double-blind, placebo-controlled
peripheral arterial disease. J Gen Intern Med 18:461-467, 2003. study of the effects of policosanol in patients with intermittent
31. Wattanakit K, Willliams JE, Schreiner PJ, et al: Association of anger claudication. Angiology 50:123-130, 1999.
proneness, depression, and low social support with peripheral 56. Castano G, Mas R, Fernandez L, et al: Effects of policosanol and
arterial disease. The Atherosclerosis Risk in Communities Study. lovastatin in patients with intermittent claudication: A double-blind
Vasc Med 10:199-206, 2005. comparative pilot study. Angiology 54:25-38, 2003.
32. Antithrombotic Trialists’ Collaboration: Collaborative meta-analysis 57. Fernandez L, Mas R, Illnait J, et al: Policosanol: Results of a
of randomised trials of antiplatelet therapy for prevention of death, postmarketing surveillance control on 27,879 patients. Curr Ther
© Elsevier. Es una publicación MASSON. Fotocopiar sin autorización es un delito.
myocardial infarction, and stroke in high risk patients. BMJ Res 59:717-722, 1998.
324:71-86, 2002. 58. Meltzer J, Brignoli R, Diehm C, et al: Meta-analysis of the Tibetan
33. Aronow WS: Antiplatelet therapy in peripheral vascular disease. herbal fixed formula Padma 28 in peripheral arterial disease.
Curr Drug Targets Cardiovasc Haematol Disord 4:265-267, 2004. Presented at the 11th Annual Symposium on Complementary
34. CAPRIE Steering Committee: A randomized, blinded, trial of Health Care, Exeter, UK, November 18, 2004.
clopidogrel versus aspirin in patients at risk of ischaemic events 59. Sallon S, Beer G, Rosenfeld J, et al: The efficacy of Padma 28, a herbal
(CAPRIE). Lancet 348:1329-1339, 1996. preparation, in the treatment of intermittent claudication: a controlled
35. Cost information from Walgreen’s Pharmacy, Tucson, AZ, as of double-blind pilot study with objective assessment of chronic occlusive
December 7, 2005. arterial disease patients. J Vasc Invest 4:129-136, 1998.
36. FDA MedWatch: Accessed from http://www.fda.gov/medwatch/ 60. Mulrow C, Lawrence V, Ackerman R, et al: Garlic: Effects on
SAFETY/1998/ticlid2.htm on December 2, 2005. cardiovascular risk and disease, protective effects against cancer,
37. Dawson DL: Comparative effects of cilostazol and other therapies and clinical adverse effects. Evidence Report/Technology
for intermittent claudication. Am J Cardiol 87(Suppl):19D-27D, Assessment No. 20. (AHRQ Publication No. 01-E023). Rockville,
2001. MD, Agency for Healthcare Research and Quality, October 2000.
38. Jung F, Mrowietz C, Kiessewetter H, et al: Effect of Ginkgo biloba 61. Ackermann RT, Mulrow CD, Ramirez G, et al: Garlic shows
on fluidity of blood and peripheral microcirculation in volunteers. promise for improving some cardiovascular risk factors.
Arzneimittelforschung 40:589-593, 1990. Arch Intern Med 161:813-824, 2001.
39. Yoshikawa T, Naito Y, Kondo M: Ginkgo biloba leaf extract: Review 62. Jung EM, Jung F, Mrowietz C, et al: Influence of garlic powder on
of biological actions and clinical applications. Antioxid Redox Signal cutaneous microcirculation. A randomized placebo controlled
1:469-480, 1999. double-blind cross-over study in apparently healthy subjects.
40. Bauer U: Six-month double-blind randomized clinical trial of Arzneimittelforschung 41:626-630, 1991.
Ginkgo biloba extract versus placebo in two parallel groups in 63. Baluchnejadmojarad T, Roghani M: Endothelium-dependent and
patients suffering from peripheral arterial insufficiency. -independent effect of aqueous extract of garlic on vascular reactivity
Arzneimittelforschung 34:716, 1984. in diabetic rats. Fitoterapia 74:630-637, 2003.